Alinari, Lapo <br/><br/>
Novel targeted therapies for mantle cell lymphoma.  [electronic resource] 

 -  Oncotarget  Feb 2012 
 - 203-11 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.426  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antigens, CD20--immunology<br/>Antigens, Differentiation, B-Lymphocyte--immunology<br/>B-Lymphocytes--pathology<br/>Cell Cycle--physiology<br/>Clinical Trials as Topic<br/>Cyclin D1--metabolism<br/>DNA Repair<br/>Female<br/>Histocompatibility Antigens Class II--immunology<br/>Humans<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>NF-kappa B--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Piperidines<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Purines--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Quinazolinones--pharmacology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Translocation, Genetic